Abstract:To the Editor: We read with interest the review by Raevens et al. (1) on hepatopulmonary syndrome (HPS) and portopulmonary hypertension. The diagnosis of HPS requires the presence of liver disease, intrapulmonary vascular dilatation (IPVD) and arterial oxygenation defect. Contrast-enhanced echocardiography (CEE) and technetium-99m-labelled macroaggregated albumin (MAA) lung perfusion scan were both wellaccepted methods for detecting IPVD. Nonetheless, in recent reviews MAA scan was only considered as a complementary tool (1, 2). The diminishing role of MAA scan was in large part due to inferior diagnostic accuracy revealed in previous studies (3–5). However, we believe the exact role of MAA scan could not be defined based on the current literature. Two main techniques have been used to determine the shunt fraction from MAA scans, including wholebody uptake and brain uptake. In the former, shunt fraction is calculated based on the technetium uptake in the entire body outside the lungs, whereas the latter is based on uptake in the brain, which is assumed to receive 13% of the cardiac output (4). Although whole-body uptake is more widely recognized in nuclear medicine, brain uptake was recommended for HPS (2), because whole-body scans take considerable time and may be associated with increased risk of overestimating the shunt fraction as a result of MAA particles breaking down. However, the diagnostic accuracy of these two techniques has not been compared directly. In addition, the technical aspects which could potentially influence the diagnostic accuracy (i.e., MAA particle size, body position during MAA injection and scanning protocol) have also not been standardized on basis of trials. Previous studies have shown that MAA scan has very high specificity but the sensitivity varied widely from 20 to 96% (3–5). These results have been attributed to operator-dependent aspects and the shunt fraction cut-off value of 6%, which was derived from only ten healthy subjects (4). However, we noted that the severity of HPS based on partial pressure of oxygenation (PaO2) appears to have an influence on the brain uptake. After combining the data from the most influential studies (3–5), we found that the sensitivity of MAA scan was virtually 100% (42/44) in patients with severe and very severe HPS, whereas it was only 23.8% (5/21) in those with mild and moderate HPS (Fig. 1). In summary, further studies are warranted to standardize MAA scan and comprehend the influence of the severity of HPS on diagnostic accuracy.

Significance of Lung Perfusion Scanning with Technetium Labeled Macroaggregated Albumin and Pulmonary Function Assay for Diagnosis of Early Hepatopulmonary Syndrome

Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake

99 Tc M -MAA Imaging Evaluation in the Diagnosis of Hepatopulmonary Syndrome and Its Application in Liver Transplantation

The role of macroaggregated albumin lung perfusion scan in hepatopulmonary syndrome: are we ready to draw conclusions?

Hepatopulmonary syndrome: Case report of the evidence of intrapulmonary shunt on 99mTc-MAA scintigraphy and contrast transthoracic echocardiography

Hepatopulmonary Syndrome: the Role of Intra-Abdominal Hypertension and A Novel Mouse Model

Differential Diagnosis of Hemophagocytic Syndrome by 18F-FDG PET/CT: A Meta-Analysis

Measurement of Intrapulmonary Vascular Changes in Hepatopulmonary Syndrome with 16-Slice CT Volume Measuring

Diagnosis and management of hepatopulmonary syndrome

[Lung Expression of Tissue Factor Mrna and Its Significance in a Rat Model of Hepatopulmonary Syndrome].

Pulmonary transit time derived from pulmonary angiography for the diagnosis of hepatopulmonary syndrome

A Cohort Study of Regional Liver Function Assessment Using 99Mtc-Gsa Single-photon Emission Computed Tomography (SPECT)/CT Fusion Imaging in Perihilar Cholangiocarcinoma

The pulmonary manifestation of hepatopulmonary syndrome presented by CT and DSA based on pathologic changes

Measurement Study of Intrapulmonary Vascular Changes on HPS

Favorable Outcomes of Liver Transplantation for Hepatopulmonary Syndrome

Clinical features of hepatopulmonary syndrome in cirrhotic patients

Multi-slice CT Study of Intrapulmonary Vascular Changes in HPS

Quantitative Analysis of Lung Perfusion in Patients with Idiopathic Pulmonary Arterial Hypertension

[Pilot Study on Clinical Application of Hepatic Perfusion with Multi-Slice Spiral CT].

CT Perfusion at Early Stage of Hepatic Diffuse Disease

[Risk factors predicting the prognosis of orthotopic liver transplantation in hepatopulmonary syndrome].